Impacts of COVID-19 on BBVSTI testing, care and treatment: Medicare data analysis (Record no. 2614)

MARC details
000 -LEADER
fixed length control field	01097nam a22002417a 4500
005 - DATE AND TIME OF LATEST TRANSACTION
Date and Time of Latest Transaction	20220616115336.0
110 ## - MAIN ENTRY--CORPORATE NAME
Main entry -Corporate name in direct order	WHO Collaborating Centre for Viral Hepatitis
110 ## - MAIN ENTRY--CORPORATE NAME
Main entry -Corporate name in direct order	Peter Doherty Institute for Infection and Immunity
245 ## - TITLE
Title	Impacts of COVID-19 on BBVSTI testing, care and treatment: Medicare data analysis
257 ## - COUNTRY OF ORIGIN
Country of origin	Australia
264 ## - PUBLICATION
Place of publication	Melbourne
Name of publisher	Peter Doherty Institute for Infection and Immunity
Date of publication	2021
300 ## - PHYSICAL DESCRIPTION
Physical description	17p.
546 ## - LANGUAGE
Language	English
653 ## - SUBJECT
Subject	General reference: Statistics
653 ## - SUBJECT
Subject	General reference: Other communicable diseases
856 ## - Web Address
URL	https://www.doherty.edu.au/uploads/content_doc/COVID-19_impacts_-_BBVSTI_treatment_and_care_(data_to_September2020).pdf
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Item type	Book/report
520 ## - SUMMARY, ETC.
Content notes:	During the period affected by COVID-19 there were substantial declines in hep screening, STI screening and hep B monitoring, and an acceleration in the decline in hep C monitoring. <br/><br/>Related term: Coronavirus

Holdings
Withdrawn status	Lost status	Source of classification or shelving scheme	Damaged status	Loan status	Home library	Current library	Shelving location	Date acquired	Total Checkouts	Date last seen	Price effective from	Koha item type
		Other/Generic Classification Scheme		Available	Library	Library	Online	19/03/2021		19/03/2021	19/03/2021	Book/report